Inventor · disambiguated record
Yuanli Li
Also filed as: LI YUANLI
6 granted patents·4 pending applications·10 citations·filing 2012–2023
74Inventor score
Top patents by PatentIndex Score
10 records- 0185US11833212B2Linker peptide for constructing fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2021·Granted Dec 5, 2023·1 cites·20 claims
- 0283US11123438B2Linker peptide for constructing fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2016·Granted Sep 21, 2021·6 cites·19 claims
- 0374US2024108743A1Linker peptide for constructing fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2023·Application pending·0 cites
- 0472US11161904B2Anti-PD-1 antibody and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2017·Granted Nov 2, 2021·1 cites·27 claims
- 0570US11884725B2Antibody against TIM-3 and application thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Granted Jan 30, 2024·1 cites·20 claims
- 0670US2023073411A1Homodimer-type bispecific antibody against her2 and cd3 and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 0766US2021371526A1Homodimeric bispecific antibody, preparation method therefor and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 0857US9611502B2Method for simultaneously measuring activity of various enzymes by using multi-wavelength absorption single channelUNIV CHONGQING MEDICAL·Filed 2012·Granted Apr 4, 2017·1 cites·9 claims
- 0948US2022242926A1Fgf21 fc fusion protein, glp-1 fc fusion protein, and combination therapeutic agent comprising same and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2020·Application pending·0 cites
- 1040US11471513B2Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of sameAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2016·Granted Oct 18, 2022·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Yuanli Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →